Grillo, F. http://orcid.org/0000-0001-6477-3182
Paudice, M. http://orcid.org/0000-0003-4188-4247
Gambella, A. http://orcid.org/0000-0001-7826-002X
Bozzano, S.
Sciallero, S.
Puccini, A. http://orcid.org/0000-0002-2492-4043
Lastraioli, S.
Dono, M. http://orcid.org/0000-0003-1280-0278
Parente, P. http://orcid.org/0000-0003-0591-6723
Vanoli, A.
Angerilli, V.
Fassan, M.
Mastracci, L. http://orcid.org/0000-0003-0193-5281
Funding for this research was provided by:
Università degli Studi di Genova
Article History
Accepted: 25 April 2023
First Online: 7 June 2023
Declarations
:
: M.F. has been involved in consulting/advisory roles in Astellas Pharma, Pierre Fabre, MSD, GlaxoSmithKline, Amgen, Novartis and Roche, and received research funding from Astellas Pharma, QED Therapeutics, Diaceutics and Macrophage Pharma.